Kudos will help Pfizer increase the reach and engagement of its clinical research by showcasing summaries and related content on a centralized platform.
(23 Jul 2025) Kudos, the platform for showcasing research, has announced that it has been chosen by Pfizer to support the dissemination of the latter’s scientific publications. Kudos will host clinical summaries and links to related content such as peer-reviewed articles, infographics, conference posters, videos, fact sheets, and more. The first treatment areas to benefit will be Inflammation and Immunology, Internal Medicine, and Vaccines.
Pfizer content will be summarized and showcased alongside prestigious content from Kudos’ partnerships with academic publishers and universities. By centralizing discovery, and guiding audiences on a more curated journey through different content, Kudos will help Pfizer maximize visibility. The Kudos platform includes a rich suite of metrics including citation counts for publications, views of related content, and audience insights.
The press release is here.
